scispace - formally typeset
H

Hugh Rosen

Researcher at Scripps Research Institute

Publications -  233
Citations -  20491

Hugh Rosen is an academic researcher from Scripps Research Institute. The author has contributed to research in topics: Receptor & Agonist. The author has an hindex of 70, co-authored 232 publications receiving 19168 citations. Previous affiliations of Hugh Rosen include Free University of Berlin & National Institutes of Health.

Papers
More filters
Journal ArticleDOI

Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists.

TL;DR: It is shown that lymphocyte trafficking is altered by the lysophospholipid sphingosine-1-phosphate (S1P) and by a phosphoryl metabolites of the immunosuppressive agent FTY720.
Journal ArticleDOI

Sphingosine 1-phosphate and its receptors: an autocrine and paracrine network

TL;DR: Recent results that indicate that S1P and its receptors are required for the emigration of thymocytes from the thymus, the trafficking of lymphocytes in secondary lymphoid organs and the migration of B cells into splenic follicles are discussed.
Journal ArticleDOI

Absence of Wallerian Degeneration does not Hinder Regeneration in Peripheral Nerve.

TL;DR: It is found that nerve regeneration in the C57BL/6/Ola mice is not impeded by the presence of largely intact axons in the distal stump and absence of recruited cells, myelin debris and the absence of Schwann cell mitosis.
Journal ArticleDOI

Crystal Structure of a Lipid G Protein–Coupled Receptor

TL;DR: The crystal structure of the sphingosine 1-phosphate receptor 1 fused to T4-lysozyme in complex with an antagonist sphingolipid mimic provides a detailed view of the molecular recognition and requirement for hydrophobic volume that activates S1P1, resulting in the modulation of immune and stromal cell responses.
Journal ArticleDOI

Sphingosine 1-Phosphate (S1P) Receptor Subtypes S1P1 and S1P3, Respectively, Regulate Lymphocyte Recirculation and Heart Rate

TL;DR: S 1P1-selective agonists will be of broad utility in understanding cell functions in vitro, and vascular physiology in vivo, and the success of the chemical approach for S1P1 suggests that selective tools for the resolution of function across this broad lipid receptor family are now possible.